Fournier's gangrene and SGLT2 inhibitors: A case study
Endocrinol Diabetes Nutr (Engl Ed). 2020 Jun-Jul;67(6):423-425.
doi: 10.1016/j.endinu.2019.12.007.
Epub 2020 Apr 27.
[Article in
English,
Spanish]
Affiliations
- 1 Medicina Interna, Hospital General Universitario Gregorio Marañón, Madrid, España; Servicio de Urgencias, Hospital General Universitario Gregorio Marañón, Madrid, España. Electronic address: alejandra.garciag90@gmail.com.
- 2 Medicina Interna, Hospital General Universitario Gregorio Marañón, Madrid, España; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España.
- 3 Servicio de Urgencias, Hospital General Universitario Gregorio Marañón, Madrid, España.
No abstract available
Publication types
-
Case Reports
-
Letter
-
Review
MeSH terms
-
Aged
-
Benzhydryl Compounds / adverse effects*
-
Diabetes Mellitus, Type 2 / drug therapy
-
Fournier Gangrene / chemically induced*
-
Glucosides / adverse effects*
-
Humans
-
Male
-
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
Substances
-
Benzhydryl Compounds
-
Glucosides
-
Sodium-Glucose Transporter 2 Inhibitors
-
dapagliflozin